The History and Analysis of the Pharmaceutical Industry Pharmaceuticals Industry Analysis i 1. Origins and Evolution 2 2. Environmental Analysis (PEST) 2 3. Structural Industry Analysis (Porter’s Five Forces) 4 4. Strategic Issues Facing The Industry 5 5. Analysis of Key Industry Participants and Strategy 6 6. Pfizer – SWOT Analysis and Strategy Review 8 7. Conclusion 10 8. References 10 Pharmaceuticals Industry Analysis Page 1 Executive Summary This report provides an analytical strategic
Premium Strategic management SWOT analysis Pharmaceutical industry
PHARMACEUTICAL INDUSTRY ANALYSIS Industry Background: The total industry can broadly be classified into two categories. These are a) Patent Medicines b) Generic Medicines Patent medicines are the products that are invented by the company‚ who have their own research team working on their own laboratories. These products are patented for many years to enjoy the monopoly market. After years of business the formulation is sold in the market so that others can go into mass production. Generic
Premium Pharmaceutical industry Pharmacology
Since 1974 the Bank has committed $1.2 billion for Agricultural Development Projects (ADPs) to increase farm production and welfare among smallholders in Nigeria. OED reviewed five ADPs and a supporting Agricultural Technical Assistance Project (ATAP)‚ all implemented between 1979 and 1990. Only two of the six projects had satisfactory outcomes. In general‚ rainfed agricultural production was far below projections. Macroeconomic conditions‚ some national policies‚ and particular design and implementation
Premium Agriculture
Presentation on: Pfizer and the Pharmaceutical Industry Fletcher Leung Analyst Investment Analysis Group February 15‚ 2002 Presentation Agenda • Industry Overview: Research Based Pharmaceuticals • Pfizer – Company Specifics – Performance – Growth Drivers • Valuation – Comparables Analysis – DCF • Recommendation February 15‚ 2002 Page 2 Investment Analysis Group 1 Industry Overview Economic •Cost Effective Demographic Sociocultural •Aging Population
Premium
Amity International Business School Amity University Term Paper Report On Pharmaceutical Industry Submitted By: Akansha Neha Sandhu Rijul
Premium Pharmaceutical industry Pharmacology
Villanova University College of Commerce and Finance Spring‚ 2001 MBA 8439 – Contemporary Topics in Finance Dr. W.L. Dellva Darren Snellgrove Pharmaceutical Mergers: What’s the Rush? Drivers of Recent and Future M&A Activity TABLE OF CONTENTS i) Executive Summary ii) Introduction iii) Industry Structure iv) Reasons
Premium Pharmaceutical industry Pharmacology Drug discovery
CORPORATE SOCIAL PRACTICES IN BANGLADESH: A STUDY ON PHARMACEUTICAL SECTORS IN BANGLADESH. Report On CORPORATE SOCIAL PRACTICES IN BANGLADESH: A STUDY ON PHARMACEUTICAL SECTORS IN BANGLADESH. Course Code: BUS-498 Submitted to: Md. Jahirul Islam Lecturer‚ ASAUB Submitted by: Farhana Bhuiyan ID# 073-12-0020 BBA 3rd Batch‚ ASAUB [pic] ASA UNIVERSITY BANGLADESH December‚ 2011 Declaration of originality
Premium Corporate social responsibility
first in the 1950s. Nigeria had it’s first appearance in the Helsinki Olympic Games in 1952‚ and it’s first victory in 1954‚ when Emmanuel Ifeanjuna won a gold medal in the high jump at the Commonwealth games in Cardiff. In 1962‚ the Nationals Sports Council was set up‚ and in 1971‚ the National Sports Commission‚ and they had the following responsibilities (stated exactly as is): * To coordinate and integrate efforts to raise the standard of performance in sports in Nigeria. * To encourage
Premium Olympic Games Summer Olympic Games 2008 Summer Olympics
ON THE SOCIO-ECONOMIC DEVELOPMENT OF NIGERIA CHAPTER 1 1.0 INTRODUCTION Nigeria is by far the most populated of Africa’s countries‚ with more than one-seventh of the continent’s people. The people belong to many different ethnic groups. These groups give the country a rich culture‚ but they also pose major challenges to nation building. Ethnic strife has plagued Nigeria since it gained independence in 1960. Officially known as the ‘Federal Republic of Nigeria’‚ she has a federal form of government
Premium Nigeria
Global Pharma Industry is likely to grow at a CAGR of 5% to US $ 1 Trillion by 2013 The Pharmaceuticals Industry in India is the world’s 3 largest in terms of volume and stands 14th in terms of sale. Domestic pharma sector benefitted from increased thrust on Rural Health through bigger budgetary allocations in the Budget of 2009-10 According to PWC in 2010‚ India joined the league of Top 10 global pharmaceutical markets in terms of sales by 2020 with value reaching US$ 50 Billion. This research
Premium Pharmaceutical industry Generic drug